JP Morgan Maintains Overweight on Celestica, Raises Price Target to $425

Benzinga Newsdesk www.benzinga.com Positive 80.3%

Neg 0% Neu 0% Pos 80.3%

JP Morgan analyst Samik Chatterjee maintains Celestica (NYSE:CLS) with a Overweight and raises the price target from $410 to $425.